REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201217:nBw7gThwja&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment
Ap19
FORM 8.3 Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 14 December 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
3,056,821 2.37% 690,140 0.54%
(2) Derivatives (other than options):
597,705 0.46% 739,005 0.57%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
3,654,526 2.84% 1,429,145 1.11%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 2 207.9600 USD
Purchase 14 205.8925 USD
Purchase 16 206.1825 USD
Purchase 18 206.2327 USD
Purchase 19 206.1100 USD
Purchase 23 206.3584 USD
Purchase 24 206.0560 USD
Purchase 26 206.1946 USD
Purchase 28 206.3946 USD
Purchase 66 206.4350 USD
Purchase 100 205.9400 USD
Purchase 100 207.0800 USD
Purchase 100 206.9300 USD
Purchase 100 206.3400 USD
Purchase 100 206.2300 USD
Purchase 100 206.0200 USD
Purchase 102 207.3764 USD
Purchase 103 207.4849 USD
Purchase 121 206.8119 USD
Purchase 125 206.8509 USD
Purchase 167 206.3103 USD
Purchase 197 205.9254 USD
Purchase 200 206.0375 USD
Purchase 200 205.8000 USD
Purchase 200 205.7725 USD
Purchase 217 205.8387 USD
Purchase 331 206.0366 USD
Purchase 420 205.8533 USD
Purchase 436 205.7660 USD
Purchase 492 205.7125 USD
Purchase 656 206.4441 USD
Purchase 933 206.0061 USD
Purchase 1,114 205.9213 USD
Purchase 1,501 206.0876 USD
Purchase 1,518 205.7630 USD
Purchase 1,851 205.9818 USD
Purchase 2,032 205.7600 USD
Purchase 3,303 205.9970 USD
Purchase 3,930 205.8803 USD
Purchase 4,382 205.7911 USD
Purchase 5,310 205.9139 USD
Purchase 9,662 206.0902 USD
Sale 2 207.9600 USD
Sale 2 206.5800 USD
Sale 2 206.9450 USD
Sale 6 206.2500 USD
Sale 31 207.0864 USD
Sale 140 207.2620 USD
Sale 200 205.9450 USD
Sale 245 206.6501 USD
Sale 391 205.9381 USD
Sale 396 205.9010 USD
Sale 613 205.9295 USD
Sale 934 206.3545 USD
Sale 1,760 205.8074 USD
Sale 2,854 206.2410 USD
Sale 3,690 205.8288 USD
Sale 3,966 205.7600 USD
Sale 5,232 205.8920 USD
Sale 10,614 206.1165 USD
(b) Derivatives transactions (other than options transactions)
Product Name Nature of transaction Number of relevant securities Price per
unit
SWAP Long 1 347,945,180.0000 USD
SWAP Long 1 160,084,430.0000 USD
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 17 Dec 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201216006096/en/
(https://www.businesswire.com/news/home/20201216006096/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - Barclays PLC Just Group plc - Form 8.3 JUST GROUP PLC
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
Announcement